You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Secretory breast cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lactation Trial in Bangkok (Milk secretory supplement group, Placebo group)

Recruiting
  • Lactation
  • Milk secretory supplement group
  • Placebo group
  • Bangkok, Thailand
    Pornanong Aramwit
May 19, 2023

Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic

Not yet recruiting
  • Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8
  • +3 more
  • Biospecimen Collection
  • +7 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Nov 1, 2023

HER2-positive Breast Cancer, Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7 Trial in San Francisco (Neratinib,

Completed
  • HER2-positive Breast Cancer
  • +8 more
  • San Francisco, California
    University of California, San Francisco
Jan 6, 2023

SLPI for Prostate Cancer

Recruiting
  • Prostate Cancer
  • Prostatic Neoplasm
  • Secretory leukocyte protease inhibitor (SLPI) in prostate cancer
  • +2 more
  • Florence, Tuscany, Italy
    Careggi University Hospital
May 6, 2022

Inflammatory Breast Cancer Trial (Breast conserving surgery, Radical modified mastectomy)

Not yet recruiting
  • Inflammatory Breast Cancer
  • Breast conserving surgery
  • Radical modified mastectomy
  • (no location specified)
Nov 14, 2023

Breast Cancer, Health Knowledge, Attitudes, Practice Trial in Ankara (simulation-based breast health education)

Recruiting
  • Breast Cancer
  • Health Knowledge, Attitudes, Practice
  • simulation-based breast health education
  • Ankara, Turkey
    Hacettepe University
Sep 17, 2023

Early Detection of Breast Cancer

Recruiting
  • Breast Neoplasms
    • Ann Arbor, Michigan
      Rogel Cancer Center
    Sep 18, 2023

    Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of

    Not yet recruiting
    • Organoids
    • +2 more
    • Biopsy
    • (no location specified)
    Nov 24, 2023

    Estrogen-receptor-positive Breast Cancer, HER2/Neu-Negative Breast Cancer, Advanced Breast Cancerv Trial in Chicago

    Not yet recruiting
    • Estrogen-receptor-positive Breast Cancer
    • +3 more
    • elacestrant, palbociclib, abemaciclib, ribociclib
    • Chicago, Illinois
      Northwestern University
    Sep 25, 2023

    Breast Cancer Trial (Strength After Breast Cancer)

    Not yet recruiting
    • Breast Cancer
    • Strength After Breast Cancer
    • (no location specified)
    Sep 25, 2023

    Young Patients With Early Breast Cancer

    Not yet recruiting
    • Breast Cancer Female
    • operation
    • (no location specified)
    Sep 6, 2023

    Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

    Not yet recruiting
    • Anatomic Stage I Breast Cancer AJCC v8
    • +2 more
    • Biospecimen Collection
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Nov 22, 2022

    Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma

    Not yet recruiting
    • Anatomic Stage 0 Breast Cancer AJCC v8
    • +3 more
    • Accelerated Partial Breast Irradiation
    • Duarte, California
      City of Hope Medical Center
    Aug 18, 2023

    Young Breast Cancer Survivors Study

    Recruiting
    • Breast Cancer
    • No intervention
    • Columbia, South Carolina
      University of South Carolina
    Aug 9, 2023

    Breast Cancer Stage I Trial (Microwave ablation)

    Not yet recruiting
    • Breast Cancer Stage I
    • Microwave ablation
    • (no location specified)
    May 23, 2023

    Breast Cancer, Lipid Cell; Tumor, Nutrition Related Cancer Trial in Roma (Lipidomic analysis for breast cancer patients)

    Not yet recruiting
    • Breast Cancer
    • +3 more
    • Lipidomic analysis for breast cancer patients
    • Roma, Italy
      Fondazione Policlinico Universitario A. Gemelli IRCCS
    Sep 4, 2023

    Breast Cancer, Genetic Disease, BRCA2 Mutation Trial (blood sample for BRCA2 mutation detection)

    Not yet recruiting
    • Breast Cancer
    • +2 more
    • blood sample for BRCA2 mutation detection
    • (no location specified)
    Jun 1, 2023

    Lymphedema Severity on Shoulder Joint Function and Muscle

    Recruiting
    • Breast Cancer
    • Breast Cancer Female
    • Lymphedema severity stratification
    • Al Ḩayy Ath Thāmin, Giza, Egypt
      Outpatient clinic of faculty of physical therapy, Ahram Canadian
    Jul 5, 2023

    Breast Cancer Lymphedema, Survivorship, Lymphedema of Upper Limb Trial in Málaga (Resistance Therapeutic Exercise)

    Not yet recruiting
    • Breast Cancer Lymphedema
    • +2 more
    • Resistance Therapeutic Exercise
    • Málaga, Spain
      Cristina Roldán Jiménez
    Oct 30, 2023

    Breast Cancer, Breast Tumors, Breast Cancer Female Trial in United States (contrast-enhanced mammography)

    Recruiting
    • Breast Cancer
    • +3 more
    • contrast-enhanced mammography
    • Bethel Park, Pennsylvania
    • +4 more
    Oct 23, 2023

    Cultural Acceptability of Community Breast Cancer Risk

    Recruiting
    • Breast Carcinoma
    • +2 more
    • Non-Interventional Study
    • Scottsdale, Arizona
      Mayo Clinic in Arizona
    Oct 31, 2023

    "Can Do" Versus "Do Do" in Patients With Breast Cancer

    Not yet recruiting
    • Breast Cancer
    • +2 more
      • Ankara, Hacettepe Unıversity, Turkey
        Ebru Çalık Kutukcu
      Sep 1, 2023

      Breast Cancer From Serum and Urine

      Recruiting
      • Breast Neoplasm Female
      • Collect blood and urine，pathological specimens if necessary
      • Guangzhou, Guangdong, China
        Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
      Oct 20, 2023

      Patients Who Had Breast Cancer With Dense Breast Tissue

      Not yet recruiting
      • Breast Cancer
      • Questionnaire/Interview
      • Houston, Texas
        MD Anderson Cancer Center
      Nov 7, 2023

      HER2-positive Breast Cancer Trial in Amsterdam (Trastuzumab deruxtecan)

      Not yet recruiting
      • HER2-positive Breast Cancer
      • Trastuzumab deruxtecan
      • Amsterdam, Netherlands
        Antoni van Leeuwenhoek
      Aug 7, 2023